Cytek Biosciences, Inc.

NMS: CTKB
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Cytek Biosciences, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get CTKB Z-Score →

About Cytek Biosciences, Inc.

Healthcare Medical Devices
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

📊 Fundamental Analysis

Cytek Biosciences, Inc. demonstrates a profit margin of -33.0%, which is below the sector average, suggesting competitive pressure.

The company recently reported 8.1% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is -18.0%, which indicates that capital utilization is currently under pressure.

At a current price of $4.53, CTKB currently sits at the 57th percentile of its 52-week range (Range: $2.37 - $6.18).

🏥 Financial Health

🔴 Profit Margin Weak
Debt/Equity Excellent
⚠️ Revenue Growth Moderate
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$582.33M
Trailing P/E
--
Forward P/E
100.67
Beta (5Y)
1.28
52W High
$6.18
52W Low
$2.37
Avg Volume
780K
Day High
Day Low
Get CTKB Z-Score on Dashboard 🚀